IP Library Granted Patent US 7,115,730
Granted Patent B1
US 7,115,730 · App. 09/528,682 · Granted Oct 3, 2006

Immunogenic detoxified mutant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,115,730
App. No.
09/528,682
Granted
Oct 3, 2006
Kind
B1
Abstract

An immunogenic detoxified protein is provided which comprises the amino acid sequence of subunit A of an E. coli heat labile toxin (LT-A) or a fragment thereof in which at least amino acid Ala-72, numbered relative to SEQ ID NO:1, of the A subunits mutated, preferably by substitution with Arg. The toxoid is useful as vaccine against an enterotoxigenic strain of E. coli and is produced by recombinant DNA means by site-directed mutagenesis. It is also an effective adjuvant.

Claims (32)

1. A polynucleotide encoding an immunologically effective detoxified E. coli heat labile toxin (LT-A) polypeptide, wherein the polypeptide comprises SEQ ID NO:1, and further wherein the amino acid residue corresponding to Ala-72 of SEQ ID NO:1 is an arginine residue.

2. The polynucleotide of claim 1 further comprising a sequence encoding a second immunogenic antigen.

3. The polynucleotide of claim 2 wherein the second immunogenic antigen comprises a subunit B of an E. coli heat labile toxin (LT-B).

4. The polynucleotide of claim 3 , wherein the LT-A and LT-B are encoded in a polycistronic unit.

5. An expression vector comprising the polynucleotide of claim 1 .

6. An expression vector comprising the polynucleotide of claim 2 .

7. An expression vector comprising the polynucleotide of claim 3 .

8. An expression vector comprising the polynucleotide of claim 4 .

9. A host cell comprising the expression vector of claim 5 .

10. A host cell comprising the expression vector of claim 6 .

11. A host cell comprising the expression vector of claim 7 .

12. A host cell comprising the expression vector of claim 8 .

13. The host cell of claim 9 , wherein the host cell is selected from the group consisting of a bacterium, a mammalian cell, a baculovirus, an insect cell and a yeast cell.

14. The host cell of claim 13 , wherein the host cell is E. coli.

15. The host cell of claim 13 , wherein the host cell is a mammalian cell.

16. The host cell of claim 13 , wherein the host cell is an insect cell.

17. The host cell of claim 13 , wherein the host cell is a yeast cell.

18. The host cell of claim 13 , wherein the host cell produces the amino acid sequence intracellularly.

19. The host cell of claim 13 , wherein the host cell secretes the amino acid sequence.

20. The E. coli host cell of claim 14 , wherein the host cell is mutated to produce a phenotype lacking wild type LT-A.

21. A method of producing a recombinant protein comprising:

(a) providing a population of host cells according to claim 9 ; and

(b) culturing said population of cells under conditions whereby the LT-A or fragment thereof encoded by the polynucleotide in said expression vector is expressed.

22. A method of producing a recombinant protein comprising:

(a) providing a population of host cells according to claim 11 ; and

(b) culturing said population of cells under conditions whereby the LT-A or fragment thereof and the LT-B encoded by the polynucleotide in said expression vector is expressed.

23. A method of producing a recombinant protein comprising:

(a) providing a population of host cells according to claim 20 ; and

(b) culturing said population of cells under conditions whereby the LT-A or fragment thereof encoded by the polynucleotide in said expression vector is expressed.

24. A polynucleotide encoding an immunologically effective detoxified E. coli heat labile toxin (LT-A) polypeptide, wherein the polypeptide comprises SEQ ID NO:2, and further wherein the amino acid residue corresponding to Ala-72 of SEQ ID NO:1 is an arginine residue.

25. A polynucleotide encoding an immunologically effective detoxified E. coli heat labile toxin (LT-A) polypeptide, wherein the polypeptide comprises SEQ ID NO:3, and further wherein the amino acid residue corresponding to Ala-72 of SEQ ID NO:1 is an arginine residue.

26. A polynucleotide encoding an immunologically effective detoxified E. coli heat labile toxin (LT-A) polypeptide, wherein the polypeptide comprises SEQ ID NO:4, and further wherein the amino acid residue corresponding to Ala-72 of SEQ ID NO:1 is an arginine residue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2009
From: PIZZA, MARIAGRAZIA; GIULIANI, MARZIA MONICA; RAPPUOLI, RINO
To: CHIRON SPA
Reel/Frame 023245/0541 →
CHANGE OF NAME Recorded Nov 5, 2003
From: CHIRON S.P.A.
To: CHIRON S.R.L.
Reel/Frame 014699/0226 →